Worth Venture Partners’s Cellectar Biosciences CLRB Stock Holding History

Worth Venture Partners’s Portfolio CLRB Stock Details CLRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-23,130	Closed	-$1.92M	–	89
2023 Q4	$1.92M	Buy	23,130 +13,826	+149%	+$1.03M	1.04%	34
2023 Q3	$737K	Sell	9,304 -1,146	-11%	-$67.5K	0.44%	62
2023 Q2	$611K	Sell	10,450 -770	-7%	-$37K	0.34%	67
2023 Q1	$485K	Hold	11,220	–	–	0.24%	86
2022 Q4	$576K	Buy	11,220 +9,832	+708%	+$589K	0.34%	71
2022 Q3	$140K	Sell	1,388 -139	-9%	-$20K	0.09%	126
2022 Q2	$225K	Hold	1,527	–	–	0.14%	110
2022 Q1	$315K	Buy	1,527 +841	+123%	+$147K	0.15%	98
2021 Q4	$137K	Buy	+686	New	+$165K	0.07%	109
2020 Q4	–	Sell	-585	Closed	-$218K	–	110
2020 Q3	$218K	Sell	585 -745	-56%	-$294K	0.18%	88
2020 Q2	$511K	Buy	+1,330	New	+$558K	0.26%	64

Other funds holding CLRB

AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $244M AUM 80.12% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $141M AUM 783.79% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return